USPTO serial 79362794
DE MOTU CORDIS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 18, 2024
- Examiner
- POLLACK, ALISON FRIEDBERG
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with DE MOTU CORDIS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations and substances in the field of emergency medicine for the treatment of anaphylactic reactions and cardiac conditions; pharmaceutical preparations and substances for the treatment of anaphylactic reactions; pharmaceutical preparations and substances for treatment of cardiac conditions; pharmaceutical preparations and substances for treatment of heart diseases; pharmaceutical preparations for the treatment of diabetes; glucose for medical purposes; glucose in the form of pharmaceutical products, namely glucose pharmaceutical preparation for medical purposes; glucose powder for medical purposes; inhalants, namely, inhalant pharmaceutical preparations for the treatment of anaphylactic reactions and cardiac conditions; drugs to be administered by inhalation, namely, inhalant pharmaceutical for the treatment of anaphylactic reactions and cardiac conditions; pharmaceutical preparations to be inhaled for the treatment of anaphylactic reactions and cardiac conditions | ACTIVE | — |
| 009 | Downloadable computer software for data collection and management, automated calling, location tracking and sharing, and for providing information, clinical guidance and medical education and training featuring instruction in medicine for medical and health care purposes, for use in assisting with medical emergencies; downloadable application software for data collection and management, automated calling, location tracking and sharing, and for providing information, clinical guidance and medical education and training featuring instruction in medicine for medical and health care purposes, for use in assisting with medical emergencies; downloadable application software for use in medical emergencies, for providing clinical guidance, for providing medical information and for medical education and training purposes featuring instruction in medicine; downloadable application software for providing clinical guidance; downloadable application software providing medical information; downloadable application software for medical education and training purposes featuring instruction in medicine, emergency medicine and treatment of life threatening conditions; downloadable global positioning systems (GPS) software for tracking and mapping geospatial data; downloadable electronic publications in the nature of journals, information sheets, brochures, newsletters, and instruction manuals providing medical information; downloadable electronic publications in the nature of journals, information sheets, brochures, newsletters and instruction manuals in the field of medical education and training | ACTIVE | — |
| 010 | Medical apparatus for use in emergency treatment of life threatening conditions; medical devices for use in emergency treatment of life threatening conditions; inhalers for medical use, sold empty; medical inhalers sold empty and medical inhaler devices provided empty for administering pharmaceuticals; drug delivery apparatus and devices, namely, inhalers for the treatment of anaphylactic reactions and cardiac conditions, sold empty; medical apparatus, namely inhalers, for administering drugs into the lungs, sold empty; apparatus provided empty used for the inhalation of pharmaceutical preparations; filters for inhalers for medical purposes | ACTIVE | — |
| 042 | Medical, clinical, scientific and technological research services and new product design relating thereto in the emergency medicine field; medical and scientific research, namely, conducting clinical trials for others; product design and development of medical emergency treatment solutions; design and development of medical devices; product development; scientific and medical research to develop new products; Software as a Service (SaaS) service featuring non-downloadable software for data collection and management, automated calling, location tracking and sharing, and for providing information, clinical guidance and medical education and training featuring instruction in medicine for medical and health care purposes, for use in assisting with medical emergencies; provision of online non-downloadable software for data collection and management, automated calling, location tracking and sharing, and for providing information, clinical guidance and medical education and training featuring instruction in medicine for medical and health care purposes, for use in assisting with medical emergencies; provision of online non-downloadable software for use in assisting with medical emergencies, for providing clinical guidance, for providing medical information, and for medical and education training purposes featuring instruction in medicine; provision of online non-downloadable software for providing clinical guidance; provision of online non-downloadable software providing medical information; provision of online non-downloadable software for medical education and training purposes featuring instruction in medicine; hosting an online website for the provision of medical information; hosting an online website for the provision of medical education and training services | ACTIVE | — |
| 044 | Medical services; emergency medical services; telemedicine services; emergency medical services regarding anaphylactic reactions and cardiac conditions; provision of medical information regarding emergency health care including in relation to anaphylactic reactions and cardiac conditions; health care medical consultancy services; provision of medical information; provision of medical information including regarding anaphylactic reactions and cardiac conditions | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by De Motu Cordis Pty Ltd
- Other trademarks owned by De Motu Cordis Pty Ltd
- Other trademarks owned by De Motu Cordis Pty Ltd
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named DE MOTU CORDIS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 14, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 27, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 27, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 18, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 18, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 18, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 16, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 2, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 2, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 27, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 27, 2024 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 13, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 28, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 14, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 14, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 14, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jan 26, 2024 | RDX3 | NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED | — |
| Jan 26, 2024 | RDX1 | ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED | — |
| Jan 26, 2024 | RRDX | ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED | — |
| Jan 24, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 23, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 23, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Dec 14, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Dec 14, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 14, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 29, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 29, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 29, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 25, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 4, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 4, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 23, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 22, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 21, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 21, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 17, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 16, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |